Opava, Czechoslovakia

Tomas Andrysek

This inventor holds 1 USPTO granted patent. Top assignee: Galena as. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomas Andrysek. Retrieved from https://idiyas.com/inventor/tomas-andrysek-y3rckf6b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomas Andrysek

Introduction

Tomas Andrysek is a notable inventor based in Opava, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on drug formulations. His expertise and dedication have led to the development of a unique formulation of Cyclosporin, a critical medication used in various medical treatments.

Latest Patents

Tomas holds 1 patent for his Cyclosporin formulation. This patent represents a significant advancement in the delivery and effectiveness of this important drug, showcasing his commitment to improving patient care through innovation.

Career Highlights

Throughout his career, Tomas has been associated with Galena AS, a company known for its focus on developing innovative therapies. His work at Galena AS has allowed him to apply his knowledge and skills in a practical setting, contributing to the advancement of medical treatments.

Collaborations

Tomas has collaborated with several talented individuals in his field, including Milan Stuchlik and Alexander Jegorov. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Tomas Andrysek's contributions to the field of pharmaceuticals, particularly through his patent for a Cyclosporin formulation, highlight his innovative spirit and dedication to improving healthcare. His work continues to inspire others in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…